Aspiriant, LLC Novartis Ag Transaction History

Aspiriant, LLC

$2.61 Billion
Q3 2024

A detailed history of Aspiriant, LLC transactions in Novartis Ag stock. As of the latest transaction made, Aspiriant, LLC holds 2,807 shares of NVS stock, worth $276,349. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,807

Previous 2,553 9.95%

Holding current value

$276,349

Previous $271,000 18.82%

% of portfolio

0.01%

Previous 0.01%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 17, 2024	BUY	$106.13 - $120.89 $26,957 - $30,706	254 Added 9.95%	2,807 $322,000
Q2 2024 Jul 15, 2024	SELL	$92.57 - $107.37 $54,801 - $63,563	-592 Reduced 18.82%	2,553 $271,000
Q4 2023 Jan 26, 2024	SELL	$92.27 - $101.54 $60,529 - $66,610	-656 Reduced 17.26%	3,145 $317,000
Q3 2023 Oct 17, 2023	BUY	$94.73 - $105.13 $77,678 - $86,206	820 Added 27.51%	3,801 $387,000
Q2 2023 Jul 19, 2023	BUY	$92.52 - $104.91 $22,667 - $25,702	245 Added 8.95%	2,981 $300,000
Q1 2023 Apr 27, 2023	BUY	$80.03 - $92.81 $40,015 - $46,405	500 Added 22.36%	2,736 $251,000
Q4 2022 Jan 23, 2023	SELL	$75.55 - $92.52 $166,210 - $203,544	-2,200 Reduced 49.59%	2,236 $0
Q3 2022 Oct 28, 2022	BUY	$74.61 - $87.26 $447 - $523	6 Added 0.14%	4,436 $336,000
Q2 2022 Jul 25, 2022	SELL	$80.52 - $93.75 $12,158 - $14,156	-151 Reduced 3.3%	4,430 $374,000
Q1 2022 May 06, 2022	SELL	$80.11 - $90.62 $1,682 - $1,903	-21 Reduced 0.46%	4,581 $402,000
Q4 2021 Feb 14, 2022	BUY	$79.7 - $88.13 $53,478 - $59,135	671 Added 17.07%	4,602 $401,000
Q2 2021 Aug 13, 2021	BUY	$85.24 - $94.15 $102,288 - $112,980	1,200 Added 43.94%	3,931 $359,000
Q4 2020 Feb 01, 2021	SELL	$78.07 - $94.43 $117,104 - $141,645	-1,500 Reduced 35.45%	2,731 $257,000
Q3 2020 Oct 29, 2020	BUY	$82.14 - $91.0 $44,930 - $49,777	547 Added 14.85%	4,231 $367,000
Q2 2020 Aug 06, 2020	SELL	$80.93 - $91.1 $133,534 - $150,315	-1,650 Reduced 30.93%	3,684 $321,000
Q1 2020 May 05, 2020	BUY	$70.67 - $99.01 $6,218 - $8,712	88 Added 1.68%	5,334 $440,000
Q4 2019 Jan 27, 2020	BUY	$84.35 - $95.37 $1,687 - $1,907	20 Added 0.38%	5,246 $498,000
Q3 2019 Nov 04, 2019	SELL	$85.54 - $94.26 $34,814 - $38,363	-407 Reduced 7.23%	5,226 $454,000
Q2 2019 Aug 06, 2019	SELL	$75.4 - $92.8 $12,365 - $15,219	-164 Reduced 2.83%	5,633 $515,000
Q1 2019 May 03, 2019	SELL	$75.32 - $86.15 $73,813 - $84,427	-980 Reduced 14.46%	5,797 $558,000
Q4 2018 Feb 04, 2019	SELL	$73.66 - $82.02 $32,189 - $35,842	-437 Reduced 6.06%	6,777 $585,000
Q3 2018 Oct 26, 2018	SELL	$66.94 - $77.43 $41,636 - $48,161	-622 Reduced 7.94%	7,214 $623,000
Q2 2018 Aug 07, 2018	SELL	$64.91 - $73.36 $35,116 - $39,687	-541 Reduced 6.46%	7,836 $592,000
Q1 2018 May 04, 2018	BUY	$70.39 - $84.15 $589,657 - $704,924	8,377 New	8,377 $677,000
Q4 2017 Jan 31, 2018	SELL	$72.33 - $77.64 $510,505 - $547,983	-7,058 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$74.14 - $77.27 $523,280 - $545,371	7,058	7,058 $606,000

Others Institutions Holding NVS

# of Institutions

1,437

Shares Held

131M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $212B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aspiriant, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aspiriant, LLC with notifications on news.

Account